UK markets closed

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.02+0.33 (+2.82%)
At close: 04:00PM EDT
12.26 +0.24 (+2.00%)
After hours: 07:42PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-104,699
-104,699
-101,067
-85,805
-52,243
Depreciation & amortisation
2,469
2,469
1,546
974
888
Stock-based compensation
25,257
25,257
22,854
16,450
5,768
Change in working capital
-6,030
-6,030
43,023
46
2,325
Other working capital
-82,683
-82,683
-35,828
-68,107
-43,271
Other non-cash items
2,260
2,260
1,989
1,256
1,038
Net cash provided by operating activities
-81,067
-81,067
-31,866
-66,907
-42,221
Cash flows from investing activities
Investments in property, plant and equipment
-1,616
-1,616
-3,962
-1,200
-1,050
Purchases of investments
0
0
-201,320
-87,226
0
Sales/maturities of investments
107,562
107,562
159,400
12,000
0
Net cash used for investing activities
105,946
105,946
-45,882
-76,426
-1,050
Cash flows from financing activities
Common stock issued
52,081
52,081
45,344
0
105,398
Other financing activities
-
-
1
-2
-485
Net cash used provided by (used for) financing activities
53,007
53,007
46,409
1,284
108,108
Net change in cash
77,886
77,886
-31,339
-142,049
64,837
Cash at beginning of period
114,125
114,125
145,464
287,513
222,676
Cash at end of period
192,011
192,011
114,125
145,464
287,513
Free cash flow
Operating cash flow
-81,067
-81,067
-31,866
-66,907
-42,221
Capital expenditure
-1,616
-1,616
-3,962
-1,200
-1,050
Free cash flow
-82,683
-82,683
-35,828
-68,107
-43,271